Harald Reinhart - May 24, 2021 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Role
Chief Medical Officer
Signature
/s/ Bruce A. Blefeld, Attorney-in-Fact
Stock symbol
ZLAB
Transactions as of
May 24, 2021
Transactions value $
-$2,257,840
Form type
4
Date filed
5/26/2021, 08:18 PM
Next filing
Jun 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZLAB Ordinary Shares Options Exercise $167K +8K $20.90 8K May 24, 2021 Direct F1
transaction ZLAB Ordinary Shares Sale -$1.3M -8K -100% $162.37* 0 May 24, 2021 Direct F1
transaction ZLAB Ordinary Shares Options Exercise $167K +8K $20.90 8K May 25, 2021 Direct F1
transaction ZLAB Ordinary Shares Sale -$1.29M -8K -100% $161.66* 0 May 25, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -8K -9.52% $0.00 76K May 24, 2021 Ordinary Shares 8K $20.90 Direct F1, F2
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -8K -10.53% $0.00 68K May 25, 2021 Ordinary Shares 8K $20.90 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 The options vest in equal annual installments over five years beginning on 03/28/2019, the first anniversary of the date of grant.